Pretty quickly I'd reckon they've had plenty of time and there were undrilled walkup targets from previous operators. Bit surprised the tenement haven't been granted.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025